The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Stroke prevention in atrial fibrillation: An Asian perspective
Abstract
Summary: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. In 2050, it is estimated that there will be 72 million AF patients in Asia, accounting for almost 2.9 million patients suffering from AF-associated stroke. Asian AF patients share similar risk factor profiles as non-Asians, except that more Asians have a history of previous stroke. Clinical challenges are evident in the field of stroke prevention in AF, amongst Asians. Existing stroke and bleeding risk scores have not been well-validated in Asians. Asians are prone to bleeding when treated with warfarin, and the optimal international normalised ratio (INR) for warfarin use is yet to be determined in Asians, though Asian physicians tend to keep it in a lower range (e.g. INR 1.6–2.6) for elderly patients despite limited evidence to justify this. In general, warfarin is ‘difficult’ to use in Asians due to higher risk of bleeding and higher stroke rate in Asians than in non-Asians, as shown in randomised controlled trials. Excess of bleeding was not found in Asians when novel oral anticoagulants (NOACs) were used. Besides, the superiority of NOACs to warfarin in reducing thromboembolism was maintained in Asians. Therefore NOACs are preferentially indicated in Asians in terms of both efficacy and safety. Also, some preliminary data suggest that Asian patients with AF might not be the same. Future prospective randomised trials are needed for the selection of NOACs according to different ethnic background. Note: The review process for this manuscript was fully handled by Christian Weber, Editor in Chief.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citationGo, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
van Asch, C. J., Luitse, M. J., Rinkel, G. J., van der Tweel, I., Algra, A., & Klijn, C. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70340-0 · Cited by 2,658
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564 · cited 1×
“Since Asia is the most populated area in the world, the burden of AF in Asia may actually exceed that in Western countries, and indeed, it has been estimated that in 2050 there will be 72 million AF patients in Asia (4), more than double the combined numbers of patients from Europe and the United States (5, 6).”
Background(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Krijthe, B. P., Kunst, A., Benjamin, E. J., Lip, G. Y. H., Franco, O. H., Hofman, A., Witteman, J. C. M., Stricker, B. H., & Heeringa, J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht280 · Cited by 1,419
Self-citationEffect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose
Rieder, M. J., Reiner, A. P., Gage, B. F., Nickerson, D. A., Eby, C. S., McLeod, H. L., Blough, D. K., Thummel, K. E., Veenstra, D. L., & Rettie, A. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044503 · Cited by 1,399
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
Hylek, E. M., Go, A. S., Chang, Y., Jensvold, N. G., Henault, L. E., Selby, J. V., & Singer, D. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022913 · Cited by 1,277
Atrial fibrillation management: a prospective survey in ESC Member Countries
Nieuwlaat, R., Capucci, A., Camm, A. J., Olsson, S. B., Andresen, D., Davies, D. W., Cobbe, S., Breithardt, G., Le Heuzey, J.-Y., Prins, M. H., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi505 · Cited by 829
Hylek, E. M., Skates, S. J., Sheehan, M. A., & Singer, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350802 · Cited by 789
Shen, A. Y.-J., Yao, J. F., Brar, S. S., Jorgensen, M. B., & Chen, W. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.098 · Cited by 656
(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)83303-x · Cited by 539
Hart, R. G., Pearce, L. A., McBride, R., Rothbart, R. M., & Asinger, R. W. (1999) · Stroke · doi:10.1161/01.str.30.6.1223 · Cited by 533
Wan, Y., Heneghan, C., Perera, R., Roberts, N., Hollowell, J., Glasziou, P., Bankhead, C., & Xu, Y. (2008) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.796185 · Cited by 514
Olesen, J., Torp-Pedersen, C., Hansen, M., & Lip, G. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0175 · Cited by 485
Self-citationApostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2013) · Chest · doi:10.1378/chest.13-0054 · Cited by 482
Self-citationThe Global Burden of Atrial Fibrillation and Stroke
Lip, G. Y. H., Brechin, C. M., & Lane, D. A. (2012) · Chest · doi:10.1378/chest.11-2888 · Cited by 379
Self-citationHusted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0443 · Cited by 365
Self-citationHusted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0403 · Cited by 364
Self-citationGallagher, A., Setakis, E., Plumb, J., Clemens, A., & van Staa, T.-P. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0353 · Cited by 359
Hori, M., Connolly, S. J., Zhu, J., Liu, L. S., Lau, C.-P., Pais, P., Xavier, D., Kim, S. S., Omar, R., Dans, A. L., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.000990 · Cited by 327
Akao, M., Chun, Y.-H., Wada, H., Esato, M., Hashimoto, T., Abe, M., Hasegawa, K., Tsuji, H., & Furuke, K. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.12.002 · Cited by 236
YASAKA, M., MINEMATSU, K., & YAMAGUCHI, T. (2001) · Internal Medicine · doi:10.2169/internalmedicine.40.1183 · Cited by 221
Rietbrock, S., Heeley, E., Plumb, J., & van Staa, T. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.03.010 · Cited by 211
Roldán, V., Marín, F., Manzano-Fernández, S., Gallego, P., Vílchez, J. A., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1623 · Cited by 190
Self-citationTakahashi, H., Wilkinson, G. R., Caraco, Y., Muszkat, M., Kim, R. B., Kashima, T., Kimura, S., & Echizen, H. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.26a · Cited by 190
Gallego, P., Roldan, V., Marín, F., Romera, M., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0556 · Cited by 187
Self-citationPacker, M., Medina, N., & Yushak, M. (1985) · Circulation · doi:10.1161/01.cir.71.4.761 · Cited by 184
Coppens, M., Eikelboom, J. W., Hart, R. G., Yusuf, S., Lip, G. Y. H., Dorian, P., Shestakovska, O., & Connolly, S. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs314 · Cited by 184
Self-citationHusted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-10-0772 · Cited by 182
Self-citationSteg, P. G., Alam, S., Chiang, C., Gamra, H., Goethals, M., Inoue, H., Krapf, L., Lewalter, T., Merioua, I., Murín, J., et al. (2011) · Heart · doi:10.1136/heartjnl-2011-300550 · Cited by 164
Self-citationStroke prevention in atrial fibrillation—An Asian stroke perspective
Tse, H., Wang, Y. J., Ai-Abdullah, M. A., Borromeo, A., Chiang, C., Krittayaphong, R., Singh, B. B., Vora, A. M., Wang, C., Zubaid, M., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.03.017 · Cited by 157
Self-citationYou, J. H. S., Chan, F. W. H., Wong, R. S. M., & Cheng, G. Y.-M. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02361.x · Cited by 139
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008): Digest Version
JCS Joint Working Group (2010) · Circulation Journal · doi:10.1253/circj.cj-88-0001 · Cited by 139
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) : Digest Version
Ogawa, S., Aizawa, Y., Atarashi, H., Inoue, H., Kamakura, S., Koretsune, Y., Kumagai, K., Mitamura, H., Okumura, K., Sugi, K., et al. (2010) · Japanese Circulation Journal-english Edition · Cited by 130
Lin, L., Lee, C., Yu, C., Tsai, C., Lai, L.-P., Hwang, J., Chen, P., & Lin, J.-L. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.033 · Cited by 124
Wallace, E., Dillon, C., Dimitrov, B. D., Fahey, T. P., & Keogh, C. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-02-0061 · Cited by 122
Inoue, H., Okumura, K., Atarashi, H., Yamashita, T., Origasa, H., Kumagai, N., Sakurai, M., Kawamura, Y., Kubota, I., Matsumoto, K., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0290 · Cited by 122
Apostolakis, S. Z., Lane, D. A., Buller, H. R., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0552 · Cited by 116
Self-citationHeuzey, J. L., BREITHARDT, G. E., Camm, A. J., Crijns, H. J. G. M., Dorian, P., Kowey, P. R., Merioua, I., Prystowsky, E. N., Schwartz, P. J., Torp-Pedersen, C. T., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.012 · Cited by 109
Albertsen, I. E., Rasmussen, L. H., Overvad, T. F., Graungaard, T., Larsen, T. B., & Lip, G. Y. H. (2013) · Stroke · doi:10.1161/strokeaha.113.000883 · Cited by 101
Self-citationSuzuki, S. S., Yamashita, T., Kato, T., Fujino, T., Sagara, K., Sawada, H., Aizawa, T., & Fu, L.-T. (2007) · Circulation Journal · doi:10.1253/circj.71.761 · Cited by 101
Ogawa, S., Aonuma, K., Tse, H., Huang, D., Huang, J., Kalman, J. M., Kamakura, S., Nair, M., Shin, D., Stiles, M. K., et al. (2013) · Journal of Arrhythmia · doi:10.1016/j.joa.2013.03.002 · Cited by 84
Guo, Y., Apostolakis, S. Z., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., & Lip, G. Y. H. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.052 · Cited by 80
Self-citationPisters, R., Nieuwlaat, R., Lane, D. A., Crijns, H. J. G. M., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-08-0539 · Cited by 56
Self-citationLip, G. Y. H., Lin, H., Hsu, H., Su, T., Chen, M.-F., Lee, Y., & Chien, K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.076 · Cited by 46
Self-citationGuo, Y., Pisters, R., Apostolakis, S. Z., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.187 · Cited by 39
Self-citationAtrial fibrillation management in Asia: From the Asian expert forum on atrial fibrillation
Chiang, C., Zhang, S., Tse, H., Teo, W. S., Omar, R., & Sriratanasathavorn, C. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.12.033 · Cited by 32
Self-citationAmerena, J. V., Chen, S., Sriratanasathavorn, C., Cho, J. G., Huang, D., Omar, R., Tse, H., & King, A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.08.046 · Cited by 18
Optimal International Normalized Ratio for Atrial Fibrillation in Asians and Japanese
Wang, K.-L., & Chiang, C. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0885 · Cited by 15
Self-citationKomatsu, T., Tachibana, H., Satō, Y., Ozawa, M., Kunugida, F., Orii, M., & Nakamura, M. (2010) · International Heart Journal · doi:10.1536/ihj.51.24 · Cited by 14
Cited by
Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights
Kornej, J., Börschel, C. S., Benjamin, E. J., & Schnabel, R. B. (2020) · Circulation Research · doi:10.1161/circresaha.120.316340 · Cited by 1,516
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H.-C., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2015) · Europace · doi:10.1093/europace/euv309 · Cited by 1,113
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M., Werring, D., et al. (2018) · Chest · doi:10.1016/j.chest.2018.07.040 · Cited by 939
Self-citationStroke prevention in atrial fibrillation
Freedman, B., Potpara, T. S., & Lip, G. Y. H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31257-0 · Cited by 463
Self-citationLarsen, T. B., Skjøth, F., Nielsen, P. B., Kjældgaard, J. N., & Lip, G. Y. H. (2016) · BMJ · doi:10.1136/bmj.i3189 · Cited by 441
Self-citation
Metadata
- Authors
- Wang, K.-L., Lip, G. Y. H., & Chiang, C.-E.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2014
- Volume
- 112
- Issue
- 05
- Pages
- 789-797
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2126858523
- Cited by
- 287
- References
- 57
- FWCI
- 20.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.